Literature DB >> 4175634

Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone.

I R Mackay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4175634

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


× No keyword cloud information.
  17 in total

Review 1.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

Review 2.  Chronic hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

3.  Serum IgG and renal transplantation.

Authors:  G Ku; Z Varghese; O N Fernando; R Baillod; J P Hopewell; J F Moorhead
Journal:  Br Med J       Date:  1973-12-22

4.  Chronic active hepatitis in children.

Authors:  R S Dubois; A Silverman; T L Slovis
Journal:  Am J Dig Dis       Date:  1972-07

5.  Treatment of chronic active hepatitis in children.

Authors:  R S Dubois; A Silverman
Journal:  Postgrad Med J       Date:  1974-06       Impact factor: 2.401

6.  Chronic hepatitis.

Authors:  I R Mackay
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

7.  Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

Authors:  W H Summerskill; M G Korman; H V Ammon; A H Baggenstoss
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

8.  An evaluation of azathioprine in severe chronic asthma.

Authors:  N G Hodges; R A Brewis; J B Howell
Journal:  Thorax       Date:  1971-11       Impact factor: 9.139

9.  Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.

Authors:  G Whelan; S Sherlock
Journal:  Gut       Date:  1972-11       Impact factor: 23.059

10.  Management of patients with difficult autoimmune hepatitis.

Authors:  Richard Parker; Ye Htun Oo; David H Adams
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.